Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder

Liang Jen Wang, Chin Bin Yeh, Yu Shu Huang, Ching Shu Tang, Wen Jiun Chou, Miao Chun Chou, Chih Ken Chen*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

10 Scopus citations


Background: Patients with bipolar disorder have neurocognitive impairments, which are associated with poor functional outcomes. Aims: This study evaluated the neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder. Methods: This was a 24-week, observational, prospective study performed in Taiwan. Participants in the study were clinically diagnosed as having bipolar disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). In total, 28 patients participated and were administered aripiprazole. Neurocognitive function was assessed as a change from baseline in the Continuous Performance Test (CPT) and the Wisconsin Card Sorting Test (WCST). Results: The 28 patients had a mean age of 18.5 ± 3.3 years. During the 24-week aripiprazole treatment, these patients had significant improvements in omission score (X;2 7.83, P 0.050) and detectability scores (X2 13.79, P 0.003) in the CPT, and perseverative errors (X2 17.42, P 0.001) in the WCST. The WCST perseverative errors scores were significantly associated with general symptom scores in Brief Psychiatric Rating Scale (BPRS) (β-1.34, P 0.024). No significant differences were found between the neurocognitive functions of patients with manic, depressive and mixed episodes from baseline to week 24. Conclusions: Adolescents and young adults with bipolar disorder experienced significant neurocognitive function improvements after treatment with aripiprazole. A randomized, controlled design is warranted to determine whether these improvements are associated with aripiprazole or the course of bipolar disorder.

Original languageEnglish
Pages (from-to)276-282
Number of pages7
JournalNordic Journal of Psychiatry
Issue number4
StatePublished - 09 2012


  • Antipsychotics
  • Attention
  • Executive function
  • Mood disorder


Dive into the research topics of 'Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder'. Together they form a unique fingerprint.

Cite this